Related Experiment Video
Updated: Aug 5, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Diffusion Magnetic Resonance Imaging Models for Detecting Brain Microstructural Abnormalities in Type 2 Diabetes: A
Yahui You1, Juan Wang1, Yongli Yan2
1Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan 430030, China.
Abstract:
The global prevalence of type 2 diabetes mellitus (T2DM) has increased more than twofold over the last thirty years. T2DM is associated with multiple complications, among which diabetic encephalopathy and accompanying cognitive impairment have drawn considerable interest. This systematic review synthesizes findings from advanced diffusion magnetic resonance imaging (dMRI) studies (published from 2009 to 2025) on T2DM-related brain microstructural abnormalities. The most common technique, diffusion tensor imaging (DTI), consistently reveals reduced white-matter integrity (lower fractional anisotropy, higher diffusivity) associated with cognitive impairment. DTI-based network analysis further identifies disrupted structural network topology, characterized by reduced global and nodal efficiency. To overcome DTI's limitations, newer techniques provide more specific insights: diffusion kurtosis imaging shows reduced tissue complexity in white matter, gray matter, and crossing-fiber regions via non-Gaussian modeling; neurite orientation dispersion and density imaging quantifies decreased neurite density; intravoxel incoherent motion assesses combined microstructural and microvascular alterations; diffusion spectrum imaging maps complex fiber architecture. These dMRI metrics may provide promising imaging markers for characterizing T2DM-related brain microstructural alterations. However, most available evidence remains cross-sectional, and further longitudinal, multicenter validation is required before these measures can be considered clinically validated biomarkers for prediction, diagnosis, or monitoring.

